特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
934730

動物用医薬品の世界市場:製品の種類別 、製品別(外部寄生虫駆除剤、内部寄生虫駆除剤、抗炎症薬、気管支拡張薬)、動物の種類別、登録別、地域別の予測と機会

Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

動物用医薬品の世界市場:製品の種類別 、製品別(外部寄生虫駆除剤、内部寄生虫駆除剤、抗炎症薬、気管支拡張薬)、動物の種類別、登録別、地域別の予測と機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: お問合せ
担当者のコメント
動物向け医薬品の2025年度までの市場動向をまとめた最新調査レポートがTechsci Researchよりリリースされました。詳細の製品区分別、動物別、登録別など細かい区分けで市場データはまとめられております。
  • 全表示
  • 概要
  • 目次
概要

動物用医薬品の市場は、コンパニオンアニマル用と産業動物用に大別されており、前者の市場が大きなシェアを占めています。最大の市場は、畜産が盛んで、コンパニオンアニマルの飼育数も多い北米地域であり、アジア太平洋地域の市場も急速に成長しています。各国政府による動物実験に関する規制の強化、電子商取引プラットフォームを介して販売される偽薬の問題など成長を阻害する要因はあるものの、市場は2025年まで着実に成長を続けると見通しです。

当レポートは、世界の動物用医薬品市場を調査したもので、各地域市場の展望、市場の力学と動向、競合状況と主要企業のプロファイルなどの情報に加え、戦略的提言も示しています。

目次

第1章 製品の概要

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別 (ワクチン、獣医用医薬品、その他)
    • 製品別
    • 動物の種類別(コンパニオンアニマル、産業動物)
    • 登録別(ジェネリック医薬品、特許薬)
    • 地域別(アジア太平洋、欧州、 北米、南米、中東・アフリカ)
    • 企業別(2019年)
  • 製品市場マップ

第6章 アジア太平洋市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別
    • 製品別
    • 動物の種類別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第7章 欧州市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別
    • 製品別
    • 動物の種類別
    • 国別
  • 欧州:国別分析
    • 英国
    • イタリア
    • フランス
    • ドイツ
    • スペイン

第8章 北米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別
    • 製品別
    • 動物の種類別
    • 国別
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第9章 南米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別
    • 製品別
    • 動物の種類別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカ市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 製品の種類別
    • 製品別
    • 動物の種類別
    • 国別
  • 中東・アフリカ:国別分析
    • UAE
    • サウジアラビア
    • カタール
    • 南アフリカ

第11章 市場の力学

  • 促進促進要因
  • 課題

第12章 市場の動向

第13章 価格分析

第14章 特許/ FDAの承認に関する分析

  • 新製品開発(承認申請の状況)
  • 企業別
  • 登録日
  • 特許期限切れ

第15章 競合情勢

  • 主要企業のプロファイル
    • Zoetis Inc
    • Merck Animal Health
    • Vetoquinol SA
    • Zoetis Inc
    • Virbac SA
    • Boehringer Ingelheim International GmbH
    • Eli Lilly & Co
    • Perrigo Co PLC
    • Sanofi SA
    • Bayer AG
    • Elanco Animal Health Inc
    • Ceva Sante Animale S.A.
    • Covetrus Inc.
    • Idexx Laboratories Inc.
    • Vetoquinol USA, Inc.
    • Norbrook Laboratories, Ltd.
    • Huvepharma EOOD
    • Adivo GmbH
    • Ceva Sant Animale
    • Phibro Animal Health Corp.

第16章 戦略的提言

第17章 免責事項

目次
Product Code: 4543

The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms.

The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region. Based on animal type, the market is segmented into companion and production animals. Companion animals tend to hold a larger share in the market as pet owners are concerned for their pet's health and well-being. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment.

The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years.

Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global animal pharmaceuticals market.
  • To classify and forecast global animal pharmaceuticals market based on product type, product, animal type, registration and region.
  • To identify drivers and challenges for global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal pharmaceuticals market.
  • To conduct pricing analysis for global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in global animal pharmaceuticals market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Manufacturers, suppliers of medicines, distributors and other stakeholders
  • Animal healthcare centers, vets
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global animal pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:

Vaccine

Veterinary

Others

  • Market, By Product:

Ectoparasiticides

  • Ivermectin
  • Cypermethrin
  • Fipronil
  • Coumaphos
  • Others

Endoparasiticides

  • Ivermectin
  • Praziquantel
  • Flubendazol
  • Milbemycin
  • Levamisole
  • Fenbendazole
  • Pyrantel
  • Others

Anti-Inflammatories

  • NSAIDs
  • Corticosteroids
  • Others

Bronchodilators

  • Theophylline
  • Albuterol
  • Others
  • Market, By Animal Type:

Companion Animals

Production Animals

  • Market, By Registration:

Generic

Patented

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • United Kingdom
  • Italy
  • France
  • Germany
  • Spain

North America

  • United States
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global animal pharmaceuticals market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Animal Pharmaceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Vaccine, Veterinary, Others)
    • 5.2.2. By Product
      • 5.2.2.1. Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
      • 5.2.2.2. Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others)
      • 5.2.2.3. Anti-Inflammatories (NSAIDs, Corticosteroids, Others)
      • 5.2.2.4. Bronchodilators (Theophylline, Albuterol, Others)
    • 5.2.3. By Animal Type (Companion Animals, Production Animals)
    • 5.2.4. By Registration (Generic, Patented)
    • 5.2.5. By Region (Asia-Pacific, Europe, North America, South America, MEA)
    • 5.2.6. By Company (2019)
  • 5.3. Product Market Map

6. Asia-Pacific Animal Pharmaceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Product
    • 6.2.3. By Animal Type
    • 6.2.4. By Country (China; India; Japan; South Korea; Australia)
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Animal Pharmaceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. India Animal Pharmaceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Japan Animal Pharmaceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Animal Type
    • 6.3.4. South Korea Animal Pharmaceuticals Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By Animal Type
    • 6.3.5. Australia Animal Pharmaceuticals Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By Animal Type

7. Europe Animal Pharmaceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Product
    • 7.2.3. By Animal Type
    • 7.2.4. By Country (United Kingdom; Italy; France; Germany; Spain)
  • 7.3. Europe: Country Analysis
    • 7.3.1. United Kingdom Animal Pharmaceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Italy Animal Pharmaceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. France Animal Pharmaceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Germany Animal Pharmaceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Animal Pharmaceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Animal Type

8. North America Animal Pharmaceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Product
    • 8.2.3. By Animal Type
    • 8.2.4. By Country (United States, Canada, Mexico)
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Animal Pharmaceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. Canada Animal Pharmaceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Mexico Animal Pharmaceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Animal Type

9. South America Animal Pharmaceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Product
    • 9.2.3. By Animal Type
    • 9.2.4. By Country (Brazil, Argentina, Colombia)
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Animal Pharmaceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Animal Pharmaceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Animal Pharmaceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa (MEA) Animal Pharmaceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Product
    • 10.2.3. By Animal Type
    • 10.2.4. By Country (UAE; Saudi Arabia; Qatar, South Africa)
  • 10.3. Middle East and Africa (MEA): Country Analysis
    • 10.3.1. UAE Animal Pharmaceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Qatar Animal Pharmaceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. South Africa Animal Pharmaceuticals Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Pricing Analysis

14. Patent / FDA Approval Analysis

  • 14.1. New Product Development (NADA, ANADA, CNADA)
  • 14.2. By Company
  • 14.3. Registration Date
  • 14.4. Patent Expiry

15. Competitive Landscape

  • 15.1. Company Profiles (Leading Companies)
    • 15.1.1. Zoetis Inc
    • 15.1.2. Merck Animal Health
    • 15.1.3. Vetoquinol SA
    • 15.1.4. Zoetis Inc
    • 15.1.5. Virbac SA
    • 15.1.6. Boehringer Ingelheim International GmbH
    • 15.1.7. Eli Lilly & Co
    • 15.1.8. Perrigo Co PLC
    • 15.1.9. Sanofi SA
    • 15.1.10. Bayer AG
    • 15.1.11. Elanco Animal Health Inc
    • 15.1.12. Ceva Sante Animale S.A.
    • 15.1.13. Covetrus Inc.
    • 15.1.14. Idexx Laboratories Inc.
    • 15.1.15. Vetoquinol USA, Inc.
    • 15.1.16. Norbrook Laboratories, Ltd.
    • 15.1.17. Huvepharma EOOD
    • 15.1.18. Adivo GmbH
    • 15.1.19. Ceva Sant Animale
    • 15.1.20. Phibro Animal Health Corp.

16. Strategic Recommendations

17. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.